2000
DOI: 10.1002/(sici)1522-726x(200004)49:4<468::aid-ccd27>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

Intravascular low-power red laser light as an adjunct to coronary stent implantation: Initial clinical experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 19 publications
0
13
0
Order By: Relevance
“…Use of LLLT is reported to enhance endothelial regeneration after damage in animal models [64,65] and in humans after coronary arterial stent implantation [66]. We have not found any reports of LLLT affecting lymphangiogenesis, but it appears reasonable to propose that lymphatic vessels may respond similarly to blood vessels because members of the VEGF family, VEGF-C and VEGF-D, stimulate lymphangiogenesis [67].…”
Section: Discussionmentioning
confidence: 83%
“…Use of LLLT is reported to enhance endothelial regeneration after damage in animal models [64,65] and in humans after coronary arterial stent implantation [66]. We have not found any reports of LLLT affecting lymphangiogenesis, but it appears reasonable to propose that lymphatic vessels may respond similarly to blood vessels because members of the VEGF family, VEGF-C and VEGF-D, stimulate lymphangiogenesis [67].…”
Section: Discussionmentioning
confidence: 83%
“…These may often provide inconclusive or even contradictory results across the test set. In-vivo evaluation has been more limited with examples of implantation into a number of animals [11,8,[15][16][17][18] that the results to date amount to a database of evidence for DLC biocompatibility rather than a systematic and conclusive investigation. It is important to state that biocompatibility is highly application-specific: some applications will require a non-adhesive surface while others will demand complete tissue integration using engineered bioactive, possibly nanostructured, material surfaces that can promote and stabilise cell attachment.…”
Section: Introductionmentioning
confidence: 99%
“…Researchers at Department of Cardiology, University Hospitals Leuven, Belgium [42] reported the biocompatibility of DLN film resulting in decreased thrombogenicity and decreased neointimal hyperplasia.…”
Section: Bursikova Vilma Et Al Recorded Laser Ablation Ofmentioning
confidence: 99%